Validea Detailed Fundamental Analysis

Validea's Multi-Factor Investor model, based on Pim van Vliet's low-volatility strategy, rates Amgen (AMGN) at 87%, signifying 'some interest' in the large-cap biotechnology stock. This model prioritizes low volatility, strong momentum, and high net payout yields. While the 87% rating reflects a favorable alignment with the strategy's fundamental and valuation criteria, it falls just below the 90% threshold typically indicating 'strong interest,' suggesting a nuanced but positive assessment.

Analysis

Amgen, Inc. (AMGN) has been rated at 87% by Validea's Multi-Factor Investor model, which is based on Pim van Vliet's strategy of targeting low-volatility stocks with strong momentum and high net payout yields. This score indicates 'some interest' from the model but falls short of the 90% threshold for 'strong interest'. The analysis reveals a mixed performance against the strategy's specific criteria: while AMGN passes on market capitalization and standard deviation, confirming its low-volatility characteristic, it only achieves a 'NEUTRAL' rating for both 'Twelve Minus One Momentum' and 'Net Payout Yield'. Critically, despite the high overall score, the detailed breakdown shows a 'FAIL' on the 'FINAL RANK', suggesting that the weaknesses in momentum and payout yield are significant enough to disqualify the stock from a full endorsement under this specific quantitative strategy.

Key Decisions for Investors

• Investors should treat the high 87% score with caution, as the model's 'FAIL' on its 'FINAL RANK' indicates AMGN does not fully meet the strategy's criteria, primarily due to neutral readings on momentum and net payout yield.
• For portfolios focused on conservative, low-volatility factors, AMGN's 'PASS' on standard deviation is a positive signal, but the stock's profile is less attractive for investors prioritizing strong momentum or high capital returns.
• Monitor for any changes in AMGN's relative price performance and capital return policies, as improvements in these areas could trigger a more definitive 'PASS' from this quantitative model in the future.